The Men’s Oncology Panel is designed for comprehensive laboratory evaluation in cases of clinical suspicion, medical follow-up, or physician recommendation.
The panel combines general blood tests, inflammatory markers, extended biochemistry, and tumor markers relevant to men.
These tests do not establish a diagnosis on their own and must be interpreted within the context of full clinical assessment.

What does the panel include?

The panel includes:

• CBC + Differential – complete blood count with white cell differential
• CRP – inflammatory marker
• Complete Biochemistry – liver function, kidney function, electrolytes, and metabolic parameters
• Urea – kidney function indicator
• PSA Total and Free PSA – markers associated with the prostate gland
• CEA – general tumor marker, commonly associated with gastrointestinal conditions
• AFP (Alpha-Fetoprotein) – marker associated primarily with liver conditions and certain testicular tumors
• CA 19-9 – marker used in evaluation of pancreatic and gastrointestinal conditions
• CA 72-4 – marker associated with gastrointestinal conditions

The combination provides a broad laboratory overview across multiple systems.

Who is this panel suitable for?

• Unexplained general symptoms
• Unintentional weight loss
• Follow-up after an oncologic diagnosis
• Monitoring after treatment
• Evaluation based on physician recommendation
• Periodic assessment in men over 50 when clinically indicated

This panel is not a universal cancer screening test and does not replace imaging studies.

What is the advantage of a panel over a single test?

A single tumor marker does not provide a complete clinical picture.
Changes in blood count or biochemistry may occur in non-malignant conditions as well.

A combined panel allows:

• Identification of abnormalities across multiple systems
• Supportive evaluation in cases of clinical suspicion
• Longitudinal monitoring of trends
• Cross-analysis of multiple laboratory markers

How is the test performed?

• A venous blood sample is collected
• Fasting for approximately 8 hours is recommended for biochemical testing
• Patients should inform their physician about ongoing medications
• Strenuous physical activity should be avoided before PSA testing

How are the results interpreted?

Tumor markers may be elevated in non-malignant conditions.
Abnormal values do not confirm the presence of cancer.
Interpretation is performed in the context of medical history, physical examination, and imaging studies when required.

⚠️ Interpretation of results requires medical consultation.
Laboratory findings should not be interpreted without full clinical evaluation.

Possible complementary investigations

• Imaging studies (ultrasound, CT, MRI)
• Biopsy when clinically indicated
• Additional tumor markers as recommended
• Hormonal evaluation

Further medical evaluation

If abnormal values are detected, further assessment is determined according to the clinical context.

Repeat testing may be recommended to evaluate trends over time.

Consultation may be recommended with:

• Primary care physician
• Urologist
• Gastroenterologist
• Oncologist

Additional Professional Information

All tests are performed in a clinical laboratory operating in accordance with established professional standards and internal quality control procedures.
Results are issued in accordance with validated laboratory protocols.

Interpretation of findings is conducted within the framework of clinical evaluation by the treating physician.